Chinook Therapeutics, Inc. — News

$40.39 USD

$0.09 (0.22%)

Source	Headline

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

1 analysts

Date	Analyst Firm	Action	Previous Grade	New Grade
2023-08-08	Wedbush	Downgrade	Outperform	Neutral
2023-08-07	Wedbush	Downgrade	Outperform	Neutral
2023-08-01	Wells Fargo	Downgrade	Overweight	Equal Weight
2023-07-31	Wells Fargo	Downgrade	Overweight	Equal Weight
2023-06-21	HC Wainwright & Co.	Maintain	Neutral	Neutral
2023-06-20	HC Wainwright & Co.	Maintain	Neutral	Neutral
2023-06-14	Evercore ISI Group	Downgrade	Outperform	In Line
2023-06-13	SVB Leerink	Downgrade	Outperform	Perform
2023-06-13	Stifel	Downgrade	Buy	Hold
2023-06-13	Evercore ISI Group	Downgrade	Outperform	In Line
2023-06-13	HC Wainwright & Co.	Downgrade	Buy	Neutral
2023-06-12	Cantor Fitzgerald	Downgrade	Overweight	Neutral
2023-06-12	SVB Leerink	Downgrade	Outperform	Perform
2023-06-12	Stifel	Downgrade	Buy	Hold
2023-06-12	William Blair	Downgrade	Outperform	Perform
2023-06-12	HC Wainwright & Co.	Downgrade	Buy	Neutral
2023-06-12	Guggenheim	Downgrade	Buy	Neutral
2023-06-11	Guggenheim	Downgrade	Buy	Neutral
2023-06-11	William Blair	Downgrade	Outperform	Perform
2023-06-11	Cantor Fitzgerald	Downgrade	Overweight	Neutral
2023-05-17	Cantor Fitzgerald	Maintain	Overweight	Overweight
2023-05-17	Cantor Fitzgerald	Maintain	Overweight	Overweight
2023-05-16	Cantor Fitzgerald	Maintain	Overweight	Overweight
2023-05-10	Wedbush	Maintain	Outperform	Outperform
2023-05-02	Guggenheim	Maintain	Buy	Buy
2023-05-02	Cantor Fitzgerald	Maintain	Overweight	Overweight
2023-05-01	Guggenheim	Maintain	Buy	Buy
2023-03-06	Piper Sandler	Maintain	Overweight	Overweight
2023-03-01	Guggenheim	Maintain	Buy	Buy
2023-02-28	Oppenheimer	Maintain	Outperform	Outperform